Vyvgart Evrópusambandið - íslenska - EMA (European Medicines Agency)

vyvgart

argenx - efgartigimod alfa - myasthenia gravis - Ónæmisbælandi lyf - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Tecvayli Evrópusambandið - íslenska - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - mergæxli - Æxlishemjandi lyf - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Omnic Hart hylki með breyttan losunarhraða 0,4 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnic hart hylki með breyttan losunarhraða 0,4 mg

astellas pharma a/s* - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg

Vesicare Mixtúra, dreifa 1 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vesicare mixtúra, dreifa 1 mg/ml

astellas pharma a/s* - solifenacinum súkkínat - mixtúra, dreifa - 1 mg/ml

Vesicare Filmuhúðuð tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vesicare filmuhúðuð tafla 5 mg

astellas pharma a/s* - solifenacinum súkkínat - filmuhúðuð tafla - 5 mg

Vesicare Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vesicare filmuhúðuð tafla 10 mg

astellas pharma a/s* - solifenacinum súkkínat - filmuhúðuð tafla - 10 mg

Arthrotec Tafla 50/0,2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

arthrotec tafla 50/0,2 mg

pfizer aps - diclofenacum natríum; misoprostolum inn - tafla - 50/0,2 mg

Arthrotec Forte Tafla 75/0,2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

arthrotec forte tafla 75/0,2 mg

pfizer aps - diclofenacum natríum; misoprostolum inn - tafla - 75/0,2 mg

Cytotec Tafla 0,2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cytotec tafla 0,2 mg

pfizer aps - misoprostolum inn - tafla - 0,2 mg

Talvey Evrópusambandið - íslenska - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - mergæxli - Æxlishemjandi lyf - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.